113 related articles for article (PubMed ID: 36740524)
21. Impact of a pharmacist in improving quality measures that affect payments to physicians.
Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
[TBL] [Abstract][Full Text] [Related]
22. Integration and compensation of pharmacists into primary care medical groups.
Woodhouse A; Clements E; Keedy C; Presnell A; Schnibben A
J Am Pharm Assoc (2003); 2019; 59(6):886-890. PubMed ID: 31521587
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Financial Outcomes Evaluation of Multimodal Pharmacist Warfarin Management of a Statewide Urban and Rural Population.
Lee JC; Horner KE; Krummel ML; McDanel DL
J Pharm Pract; 2018 Apr; 31(2):150-156. PubMed ID: 28441899
[TBL] [Abstract][Full Text] [Related]
24. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions.
MacLaren R; Brett McQueen R; Campbell J
Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188
[TBL] [Abstract][Full Text] [Related]
25. Use of Chronic Care Management Codes for Medicare Beneficiaries: a Missed Opportunity?
Gardner RL; Youssef R; Morphis B; DaCunha A; Pelland K; Cooper E
J Gen Intern Med; 2018 Nov; 33(11):1892-1898. PubMed ID: 30030734
[TBL] [Abstract][Full Text] [Related]
26. Report on financing the new model of family medicine.
Spann SJ;
Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
[TBL] [Abstract][Full Text] [Related]
27. Assessment of reimbursement in a community hospital-based pharmacist-managed outpatient transition clinic.
Huang J; Tattersall R; Morse K; Nickerson-Troy J; Clements E; Celauro L; Lovell A
Am J Health Syst Pharm; 2017 Jun; 74(11 Supplement 2):S30-S34. PubMed ID: 28506974
[TBL] [Abstract][Full Text] [Related]
28. Cost and reimbursement of providing routine vaccines in outpatient obstetrician/gynecologist settings.
Dempsey AF; Pyrzanowski J; Campbell J; Brewer S; Sevick C; O'Leary ST
Am J Obstet Gynecol; 2020 Oct; 223(4):562.e1-562.e8. PubMed ID: 32179023
[TBL] [Abstract][Full Text] [Related]
29. Assessing appropriate panel size and optimization of quality metrics for ambulatory care pharmacists in the primary care setting.
Ozbay N; King BS; Gothard MD; King CA
Am J Health Syst Pharm; 2023 Jan; 80(1):e23-e28. PubMed ID: 36165085
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting.
Watkins JL; Landgraf A; Barnett CM; Michaud L
J Am Pharm Assoc (2003); 2012; 52(2):170-4. PubMed ID: 22370379
[TBL] [Abstract][Full Text] [Related]
31. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
Scott MA; Hitch WJ; Wilson CG; Lugo AM
J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
[TBL] [Abstract][Full Text] [Related]
32. The clinical and financial impact of remote clinical oncology pharmacist engagement in community-based practices within The US Oncology Network.
Carroll M; Koselke E; Howell J; Cho J; Roman A; Keisler M; Patel T; Patel V; Mitchem T; Yarbro L; Hough S
J Oncol Pharm Pract; 2024 Jan; 30(1):165-172. PubMed ID: 37151016
[TBL] [Abstract][Full Text] [Related]
33. Pharmacist-Physician Split-Shared Visits in a Federally Qualified Health Center: Lessons Learned from a Novel Reimbursement Model using Telehealth.
Abou-Karam NM; Jump ME; Jiao J; Schmelz AN
Innov Pharm; 2022; 13(1):. PubMed ID: 36304686
[No Abstract] [Full Text] [Related]
34. Improving Organizational Sustainability of an Urban Indian Health Clinic With an Innovative Pharmacy Model.
Gallegos N; Fitzgerald L; Versackas A; Sherer E; Valdez C
J Prim Care Community Health; 2022; 13():21501319211069750. PubMed ID: 35068248
[TBL] [Abstract][Full Text] [Related]
35. Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions.
McKeirnan KC; Garrelts MacLean L
J Am Pharm Assoc (2003); 2018; 58(6):599-607. PubMed ID: 30266565
[TBL] [Abstract][Full Text] [Related]
36. Financial implications of pharmacist-led Medicare annual wellness visits.
Park I; Sutherland SE; Ray L; Wilson CG
J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of quality measure attainment with pharmacist-delivered Medicare annual wellness visits.
Osae SP; Young HN; Fricks WP; Zillich AJ
J Am Pharm Assoc (2003); 2022; 62(2):559-563. PubMed ID: 34799260
[TBL] [Abstract][Full Text] [Related]
38. Pay-for-performance model of medication therapy management in pharmacy practice.
Lenz TL; Monaghan MS
J Am Pharm Assoc (2003); 2011; 51(3):425-31. PubMed ID: 21555297
[TBL] [Abstract][Full Text] [Related]
39. A sustainable business model for comprehensive medication management in a patient-centered medical home.
Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
[TBL] [Abstract][Full Text] [Related]
40. Retrospective financial analysis of medication therapy management services from the pharmacy's perspective.
McDonough RP; Harthan AA; McLeese KE; Doucette WR
J Am Pharm Assoc (2003); 2010; 50(1):62-6. PubMed ID: 20097640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
